Cubist Pharmaceuticals Inc (CBST) Financial Statements (2024 and earlier)

Company Profile

Business Address 65 HAYDEN AVENUE
LEXINGTON, MA 02421
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2014
MRQ
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 578,558976,229
Cash and cash equivalents 91,058104,041
Short-term investments 487,500872,188
Receivables 123,15593,467
Inventory, net of allowances, customer advances and progress billings 57,66341,947
Inventory 57,66341,947
Prepaid expense and other current assets31,217
Deferred tax assets 52,108 
Other undisclosed current assets 58,28514,190
Total current assets: 869,7691,157,050
Noncurrent Assets
Property, plant and equipment 177,544166,465
Long-term investments and receivables  3,167
Long-term investments  3,167
Intangible assets, net (including goodwill) 1,104,084266,960
Goodwill 383,018114,130
Intangible assets, net (excluding goodwill) 721,066152,830
Other noncurrent assets 98,024
Prepaid expense and other noncurrent assets66,043
Other undisclosed noncurrent assets 896,400272,700
Total noncurrent assets: 2,276,052775,335
TOTAL ASSETS: 3,145,8211,932,385
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 276,955209,236
Accounts payable 31,87745,603
Accrued liabilities 245,078163,633
Deferred revenue and credits 6,4116,784
Other liabilities 7,0343,500
Other undisclosed current liabilities 20,42838,998
Total current liabilities: 310,828258,518
Noncurrent Liabilities
Long-term debt and lease obligation 1,041,322466,000
Long-term debt, excluding current maturities 1,041,322466,000
Liabilities, other than long-term debt 436,938178,993
Deferred revenue and credits 31,01034,091
Deferred tax liabilities, net 357,802103,081
Liability for uncertainty in income taxes 16,40013,900
Other liabilities 31,72627,921
Other undisclosed noncurrent liabilities (36,998)38,126
Total noncurrent liabilities: 1,441,262683,119
Total liabilities: 1,752,090941,637
Equity
Equity, attributable to parent 1,393,731990,748
Common stock 7465
Additional paid in capital 1,362,240940,969
Accumulated other comprehensive income (loss) 215(59)
Retained earnings 31,20249,773
Total equity: 1,393,731990,748
TOTAL LIABILITIES AND EQUITY: 3,145,8211,932,385

Income Statement (P&L) ($ in thousands)

9/30/2014
TTM
12/31/2013
12/31/2012
Revenues 1,054,442926,359
Cost of revenue
(Cost of Goods and Services Sold)
 (260,310)(230,057)
Gross profit: 794,132696,302
Operating expenses (847,147)(511,088)
Other undisclosed operating income 79,42551,892
Operating income: 26,410237,106
Nonoperating expense (70,054)(37,510)
Other nonoperating expense (34,890)(7,595)
Interest and debt expense (37,602)(32,991)
Other undisclosed income from continuing operations before equity method investments, income taxes 37,60232,991
Income (loss) from continuing operations before income taxes: (43,644)199,596
Income tax expense (benefit) 25,073(45,521)
Income (loss) from continuing operations: (18,571)154,075
Income (loss) before gain (loss) on sale of properties: (18,571)154,075
Net income (loss) available to common stockholders, basic: (18,571)154,075
Other undisclosed net income available to common stockholders, diluted  16,729
Net income (loss) available to common stockholders, diluted: (18,571)170,804

Comprehensive Income ($ in thousands)

9/30/2014
TTM
12/31/2013
12/31/2012
Net income (loss): (18,571)154,075
Comprehensive income (loss): (18,571)154,075
Other undisclosed comprehensive income, net of tax, attributable to parent 274126
Comprehensive income (loss), net of tax, attributable to parent: (18,297)154,201

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: